Login to Your Account



Statistics Goes Full Circle

Predicting Oncology Drug Prices An Interesting Twist to Analysis

By Brian Orelli
BioWorld Insight Contributing Writer

Wednesday, January 2, 2013

Cox Proportional Hazard Models are nothing new to those who follow oncology drugs where the statistical analysis is used to calculate survival effects of drugs. But the Alliance Life Sciences Consulting Group Inc. put an interesting twist on the statistical analysis, using it to determine what factors affect the price changes of oncology drugs.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription